Drug Use Investigation for REVOLADE (ITP)

Clinical trial NCT01416311 · COMPLETED

Trial details

NCT number: NCT01416311
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Purpura, Thrombocytopaenic, Idiopathic

Start date: 2010-12-21
Primary completion: 2020-10-16
Enrollment: 5797

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.